Avandia, an oral medication produced by GlaxoSmithKline, improves control of blood glucose levels in individuals with type-2 diabetes. Despite its ability to make insulin receptors more sensitive, Avandia does have some serious associated risks, as it can increase the chances that patients’ develop:
* stroke
* congestive heart failure
* heart attack
* liver toxicity
* severe allergic reactions